A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy

被引:0
|
作者
Nakatsuka, A
Maeshima, Y
Sarai, A
Yanai, H
Sugiyama, H
Yamasaki, Y
Makino, H
机构
[1] Okayama Univ, Dept Med & Clin Sci, Grad Sch Med & Dent, Okayama 7008558, Japan
[2] Okayama Univ, Dept Pathol, Grad Sch Med & Dent, Okayama 7008558, Japan
关键词
monoclonal immunoglobulin deposition disease (MIDD); light and heavy chain deposition disease (LHCDD); melphalan and prednisolone (MP) chemotherapy; nodular glomerulosclerosis;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We report a case of light and heavy chain deposition disease (LHCDD), a rather rare monoclonal immunoglobulin deposition disease (MIDD) with successful therapeutic effect. A 58-year-old woman suffered from proteinuria and renal insufficiency (serum creatinine 1.0 mg/dl, creatinine clearance 49.2 ml/min) in February 2003. In serum and urine samples, monoclonal IgG-kappa was detected. A bone marrow aspiration showed a slightly hypocellular marrow and plasma cell population was increased to 7.0%. Renal histological findings revealed lobulated glomeruli with nodular lesions on light microscopy, characteristic findings of MIDD. Intense deposition of IgG heavy chains in the linear pattern in the glomerular and tubular basement membranes was observed. Immunohistochemistry revealed both kappa and lambda light chain depositions in glomeruli. Electron-microscopic examination revealed fine granular electron-dense deposits accompanied by microfibrils. Based on these findings, this patient was diagnosed as LHCDD. She received three courses of melphalan and prednisone chemotherapy, resulting in disappearance of proteinuria, prevention of renal functional deterioration and the decrease of monoclonal immunoglobulin. This case clearly demonstrates that the earlier and accurate diagnosis and initiation of chemotherapy at the early stage with serum creatinine level below 4.0 mg/dl are necessary to improve renal and patient outcome.
引用
收藏
页码:221 / 227
页数:7
相关论文
共 50 条
  • [1] Nonamyloidotic monoclonal immunoglobulin deposition disease - Light-chain, heavy-chain, and light- and heavy-chain deposition diseases
    Buxbaum, J
    Gallo, G
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (06) : 1235 - +
  • [2] MECHANISMS OF DISEASE - MONOCLONAL IMMUNOGLOBULIN DEPOSITION - AMYLOIDOSIS, LIGHT CHAIN DEPOSITION DISEASE, AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASE
    BUXBAUM, J
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1992, 6 (02) : 323 - 346
  • [3] Light- and heavy-chain deposition disease (LHCDD): Difficulty in diagnosis and treatment
    Suzuki, K
    INTERNAL MEDICINE, 2005, 44 (09) : 915 - 916
  • [4] Abnormal immunoglobulin synthesis in monoclonal immunoglobulin light chain and light and heavy chain deposition disease
    Buxbaum, JN
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2001, 8 (02): : 84 - 93
  • [5] Probable light- and heavy-chain deposition disease in a patient with nodular diabetic glomerulosclerosis
    Noriko Nakamura
    Ritsuko Katafuchi
    Izumi Watanabe
    Yusuke Kuroki
    Itsuko Ishida
    Kei Hori
    CEN Case Reports, 2014, 3 (2) : 162 - 166
  • [6] Probable light- and heavy-chain deposition disease in a patient with nodular diabetic glomerulosclerosis
    Nakamura, Noriko
    Katafuchi, Ritsuko
    Watanabe, Izumi
    Kuroki, Yusuke
    Ishida, Itsuko
    Hori, Kei
    CEN CASE REPORTS, 2014, 3 (02): : 162 - 166
  • [7] MONOCLONAL IMMUNOGLOBULIN DEPOSITION DISEASE - LIGHT CHAIN AND LIGHT AND HEAVY-CHAIN DEPOSITION DISEASES AND THEIR RELATION TO LIGHT CHAIN AMYLOIDOSIS - CLINICAL-FEATURES, IMMUNOPATHOLOGY, AND MOLECULAR ANALYSIS
    BUXBAUM, JN
    CHUBA, JV
    HELLMAN, GC
    SOLOMON, A
    GALLO, GR
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) : 455 - 464
  • [8] Coexistence of Light- and Heavy-Chain Deposition Disease and Immunotactoid Glomerulopathy in a Patient with Multiple Myeloma: A Case Report
    Liang, Yaoxian
    Dong, Bao
    Jiang, Lei
    Li, Xin
    Shao, Chunying
    Yan, Yu
    Zuo, Li
    CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2022, 12 (01): : 50 - 56
  • [9] High dose chemotherapy and stem cell support in a patient of light- and heavy-chain deposition disease with abnormal marrow cell surface antigens and no monoclonal protein
    Sakakima, M
    Fujigaki, Y
    Tsuji, T
    Fukasawa, H
    Miyaji, T
    Naito, K
    Yamamoto, T
    Yonemura, K
    Ohnishi, K
    Hishida, A
    INTERNAL MEDICINE, 2005, 44 (09) : 970 - 974
  • [10] THE REQUIREMENT OF LIGHT CHAIN FOR THE SURFACE DEPOSITION OF THE HEAVY-CHAIN OF IMMUNOGLOBULIN-M
    MAINS, PE
    SIBLEY, CH
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (08) : 5027 - 5033